AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected

Sep.23
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Limited, a wholly owned subsidiary of AIR Global, has launched an offering of U.S. dollar-denominated senior unsecured notes, with proceeds primarily intended to repay its existing term loan and revolving credit facility. AIR has not disclosed the final size, maturity or coupon; Refinitiv, citing Moody's, reported an expected issuance of approximately $400 million and a Ba3 rating. AIR had about $412.4 million outstanding under the two bank facilities at June 30 and net debt of $344.8 million. In the first half of 2026, AIR's Al Fakher-led flavored shisha molasses business generated about 99% of company revenue, while New Growth Categories including Crown Switch produced $2.2 million in revenue and remained loss-making on an adjusted EBITDA basis.

Key Points

  • AIR Limited launched a U.S. dollar senior unsecured notes offering on September 21, with proceeds primarily intended to repay its term loan and revolving credit facility.
  • AIR has not disclosed the final offering size; Refinitiv, citing Moody's, reported an expected issuance of about $400 million and a Ba3 rating.
  • At June 30, approximately $384.9 million remained outstanding under the term loan and $27.5 million had been drawn under the revolving facility, totaling about $412.4 million.
  • AIR's existing bank facilities are senior secured, while the proposed notes are senior unsecured.
  • H1 2026 net debt stood at $344.8 million, with net debt/adjusted EBITDA at 2.48x.
  • The Al Fakher-led flavored shisha molasses business generated approximately $204.7 million of H1 revenue, or about 99% of total company revenue, while NGC revenue was $2.2 million and adjusted EBITDA was a $7.9 million loss.

2Firsts

September 23, 2026

According to AIR Global's September 21 announcement, its wholly owned subsidiary AIR Limited has launched an offering of U.S. dollar-denominated senior unsecured notes, with proceeds primarily intended to repay its existing term loan and revolving credit facility. AIR has not disclosed the final size, maturity or coupon; Refinitiv, citing Moody's, reported an expected issuance of approximately $400 million.

AIR Global PLC (NASDAQ: AIIR) owns the Al Fakher shisha brand and the Crown Switch vaping platform.

AIR Launches Unsecured Notes to Repay Bank Debt

AIR said the notes will be offered under Rule 144A and Regulation S and guaranteed on a senior basis by AIR Global and certain subsidiaries of AIR Limited.

The interest rate, offering price and certain other terms will be determined at pricing, subject to market conditions.

AIR said proceeds will be used to repay outstanding amounts under its term loan and revolving credit facilities, together with accrued interest, premiums, fees and expenses. Any remaining proceeds will be used for general corporate purposes and costs related to the offering.

The company did not disclose the final size of the proposed notes.

Refinitiv reported that Moody's assigned the proposed issuance a Ba3 rating and expects the offering to total approximately $400 million. Final size and terms remain subject to pricing and market conditions.

Bank Facilities Totaled About $412 Million at June-End

SEC filings show that AIR entered into a $480.2 million senior secured facilities agreement in March 2025, comprising a $405.2 million term loan and a $75 million revolving credit facility.

As of June 30, 2026:

  • approximately $384.94 million remained outstanding under the term loan;
  • $27.5 million had been drawn under the revolving facility;
  • the two totaled approximately $412.44 million.

AIR's proposed notes are senior unsecured, while its existing term loan and revolving credit facility are senior secured financing.

The company has not disclosed how much of the two bank facilities will remain outstanding after completion of the notes offering.

First-Half Net Debt at $344.8 Million, Leverage Near 2.5x

At June-end, AIR reported total borrowings of approximately $430.2 million and cash and cash equivalents of $85.4 million, resulting in net debt of $344.8 million.

Trailing-12-month adjusted EBITDA was $139.3 million, putting net debt to adjusted EBITDA at 2.48x.

AIR's disclosed leverage history shows:

PeriodNet DebtNet Debt / Adjusted EBITDA
2023$423 million3.6x
2024$335 million2.6x
2025$291 million2.1x
H1 2026$345 million2.5x

AIR reduced net debt between 2023 and 2025 before it increased by approximately $54 million in the first half of 2026.

The company lists approximately 2.5x net debt to adjusted EBITDA as its long-term leverage target and has said it plans to continue deleveraging over the medium term.

AIR completed its business combination with Cantor Equity Partners III in May and began trading on Nasdaq under the ticker AIIR on May 18.

The notes offering comes about four months after the listing.

Al Fakher-Led FSM Business Generates About 99% of Revenue

AIR reported first-half revenue of $206.9 million, up 3.7% year over year, while adjusted EBITDA was broadly flat at $71.7 million.

Its core flavored shisha molasses, or FSM, business generated approximately $204.7 million of H1 revenue across its geographic segments, equivalent to about 99% of total company revenue.

New Growth Categories, including Crown Switch, Crown Gems and Al Fakher nicotine pouches, generated $2.2 million of revenue, up from $1.6 million a year earlier.

NGC adjusted EBITDA was a loss of $7.9 million, compared with a $9.3 million loss in H1 2025. AIR attributed the loss to continued product-development and commercialization spending.

On July 29, AIR separately announced a $20 million preferred-equity investment in Canadian vaporization-technology company Greentank Innovations. The investment occurred after June 30 and is therefore not included in the H1 net-debt figures above.

AIR said the Greentank partnership will support development of Crown Switch for the U.S. market and related PMTA work. The company has also said that the timing and scale of future NGC revenue and adjusted EBITDA contributions will depend on FDA acceptance of its PMTA applications.

Follow 2Firsts for timely coverage of global tobacco and nicotine financing, capital structure and next-generation product businesses.

Cover Image: AIR Global


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-listed consumer goods group Supreme plc says it continues to expect FY27 trading to meet market expectations as the Vaping Products Duty takes effect on October 1, while maintaining a comparatively positive view of the new tax and compliance regime. Supreme has said the framework could increase compliance complexity for smaller operators and contribute to market consolidation, while its manufacturing, compliance and distribution scale may allow it to gain share. Its 88Vape brand will retain its value positioning.
Sep.18
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Swedish nicotine pouch brand Kelly White is building its strategy around adult female consumers. Founder and CEO Sophia Wilsby told 2Firsts that women accounted for around 70% of the brand’s repeat customers on HAYPP in Sweden in 2025. The interview explores female consumer segmentation, product and design differentiation, gender stereotypes, packaging regulation, and how independent brands can compete with global players such as ZYN and VELO while considering funding, partnerships and future ownership options.
Business
Sep.24
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Smoke-Free Business Hits 42% of Q2 Net Revenue as PMI’s First TNFD Report Covers Single-Use Electronics, Critical Raw Materials and IQOS Repairs
Philip Morris International has published its first report aligned with the Taskforce on Nature-related Financial Disclosures, bringing its electronics supply chain and the use and end-of-life stages of smoke-free devices and consumables into its nature-related assessment. PMI said its smoke-free business accounted for about 42% of total net revenues in the second quarter of 2026. The report says non-circular electronic products, particularly single-use items, can increase consumption of limited natural resources and also details an IQOS repair pilot. A 2040 circularity scenario tests assumptions including a 50% reduction in product waste-related costs, 10% raw-material savings and a 25% substitution rate for refurbished products versus new products.
Sep.23